KYMR
Kymera Therapeutics, Inc.
Stock
$107.39−2.73 (−2.48%)Close Oct 2, 2026
Aug 21, 2020 – Oct 2, 2026, Dividends reinvested
- Final balance
- $32,288
- CAGR
- +21.13%
- Max drawdown
- −87.51%
- Sharpe ratio
- 0.62
Loading the growth chart…
Growth of $10,000
Trailing returns (%)
Annualized from 3Y- 1M
- −9.47%
- 3M
- −5.39%
- 6M
- +25.75%
- YTD
- +38.02%
- 1Y
- +91.77%
- 3Y
- +99.28%
- 5Y
- +12.27%
- Since 2020
- +21.13%
Metrics
Since 2020| Volatility | 74.37% |
|---|---|
| Sortino ratio | 0.98 |
| Calmar ratio | 0.24 |
| Best year, 2025 | +93.41% |
| Worst year, 2022 | −60.69% |
| Positive years | 4 of 5 |
| Longest drawdown | 4.9 years |
Worst drawdowns
Since 2020| Decline | Peak | Bottom | Recovered | Length |
|---|---|---|---|---|
| −87.5% | Dec 2020 | Oct 2023 | Dec 2025 | 4.9 years |
| −27.7% | Dec 2025 | Jan 2026 | Feb 2026 | 3 months |
| −25.0% | Feb 2026 | Jun 2026 | Jun 2026 | 4 months |
| −21.6% | Aug 2020 | Sep 2020 | Oct 2020 | 1 month |
| −16.0% | Jul 2026 | Aug 2026 | Aug 2026 | 1 month |
Annual returns
2020 from Aug 21 · 2026 through Oct 2